CDKL5
Protein-coding gene in humans
From Wikipedia, the free encyclopedia
Cyclin-dependent kinase-like 5 (CDKL5) is a serine/threonine protein kinase that in humans is encoded by the CDKL5 gene. It is critically involved in early brain development and function, particularly in neuronal maturation and synaptic regulation. Mutations in CDKL5 are associated with CDKL5 deficiency disorder (CDD), a severe neurodevelopmental condition that manifests with early-onset epilepsy, developmental delay, and motor and cognitive impairment. CDKL5 is closely related to the cyclin-dependent kinase family and has been implicated in disorders such as Rett syndrome and other epileptic encephalopathies.
Gene
The CDKL5 gene is located on the X chromosome at locus Xp22.[5][6][7] It undergoes alternative splicing to produce multiple transcript variants.[5][7][8][9] Pathogenic variants in CDKL5 can result in either loss of function or altered subcellular localization of the protein, which contributes to disease pathology.[10][11][7][6] The gene is expressed predominantly in the brain and is particularly active during early developmental stages.[12][13][14]
Structure
CDKL5 encodes a serine/threonine kinase with a highly conserved catalytic domain similar to cyclin-dependent kinases (CDKs), though it functions independently of cyclins.[5][15] The C-terminal region of the protein plays a critical role in its subcellular localization and regulation.[13][14] During neuronal development, CDKL5 localizes to both the nucleus and cytoplasm, with nuclear localization being essential for its role in gene regulation and splicing.[15][16][5]
Function
CDKL5 plays a central role in neuronal function by regulating signal transduction pathways that influence dendritic spine morphology, synaptogenesis, and neuronal survival.[17][5][18] It is involved in the phosphorylation of target proteins that modulate neuronal activity and gene expression.[17][19][20] CDKL5 has also been shown to interact with nuclear speckles and influence RNA splicing machinery, which may underlie some of its neurodevelopmental functions.[15][17]
Clinical significance
Mutations in CDKL5 cause CDKL5 deficiency disorder (CDD), an X-linked dominant condition characterized by early-onset epileptic seizures, severe intellectual disability, and motor dysfunction.[21][22] CDD is considered distinct from classic Rett syndrome, although overlapping features have been noted, especially in female patients.[21] Clinical presentations of CDKL5 mutations can vary widely, and cases have been reported in both males and females.[23][24] Genetic testing for CDKL5 is recommended in infants presenting with epileptic encephalopathy of unknown origin.[25][13] Research is ongoing into potential therapies, including gene therapy[26][23] and molecular modulation of downstream targets.[5][17]
